在非小细胞肺癌中,EGFR抑制有助于G-四重复合体配体的增长抑制活性
Kai Lu1, Hsin-Chiao Wang1, Yi-Chen Tu1
1Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan.
Biochemical pharmacology
|September 8, 2023
概括
像BMVC-8C3O这样的G-四重复合联体抑制表皮生长因子受体 (EGFR) 表达,抑制非小细胞肺癌 (NSCLC) 的生长. 这种方法对抗耐药NSCLC有希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 经常具有表皮生长因子受体 (EGFR) 突变.
- 针对EGFR的疗法是有效的,但由于新的突变,耐药性会发展.
- 需要新的策略来克服NSCLC的耐治疗性.
研究的目的:
- 研究EGFR促进体中的G-四重复稳定作为抑制EGFR表达的一种方法.
- 评估G-四重复合体连接体在抑制EGFR突变NSCLC细胞生长中的疗效.
- 探索抗药性NSCLC的潜在治疗应用.
主要方法:
- 使用的碳醇衍生物BMVC-8C3O和其他G-四重复合联体.
- 在实验室中评估EGFR表达水平和癌细胞增殖.
- 在老鼠异种移植模型中评估瘤生长.
- 在耐奥西默提尼布的NSCLC细胞系中测试的疗效.
主要成果:
- BMVC-8C3O显著抑制了EGFR表达,并抑制了NSCLC细胞生长.
- 与其他G-四重复合体连接体观察到类似的效果.
- 增长抑制在细胞培养和小鼠模型中都是有效的.
- 在BMVC-8C3O的研究中,它被证明对抗耐奥西默提尼布NSCLC细胞具有有效性.
结论:
- 稳定EGFR促进器G-四重复结构是抑制NSCLC生长的可行策略.
- G-四重复合体连接体代表了NSCLC的有前途的治疗途径,包括耐药形式.
- BMVC-8C3O为EGFR突变的NSCLC患者提供了潜在的新治疗选择.
更多相关视频
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.1K
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.2K
相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
